However, as TRM formation is strictly dependent on TGF-β (79, 80), it is plausible that abundant TGF-β within the MC38 TME drives CD8+ TRM differentiation, while also mediating the exclusion of these cells from the tumour parenchyma (71). The gene discussed is TGFB1; the disease is neoplasm.